APA (7th ed.) Citation

Shrestha, N. K., Burke, P. C., Nowacki, A. S., & Gordon, S. M. (2024). Effectiveness of the 2023–2024 Formulation of the COVID-19 Messenger RNA Vaccine. Clinical Infectious Diseases, 79(2), 405. https://doi.org/10.1093/cid/ciae132

Chicago Style (17th ed.) Citation

Shrestha, Nabin K., Patrick C. Burke, Amy S. Nowacki, and Steven M. Gordon. "Effectiveness of the 2023–2024 Formulation of the COVID-19 Messenger RNA Vaccine." Clinical Infectious Diseases 79, no. 2 (2024): 405. https://doi.org/10.1093/cid/ciae132.

MLA (9th ed.) Citation

Shrestha, Nabin K., et al. "Effectiveness of the 2023–2024 Formulation of the COVID-19 Messenger RNA Vaccine." Clinical Infectious Diseases, vol. 79, no. 2, 2024, p. 405, https://doi.org/10.1093/cid/ciae132.